These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 36253442

  • 1. Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis.
    Kishi T, Ikuta T, Sakuma K, Okuya M, Hatano M, Matsuda Y, Iwata N.
    Mol Psychiatry; 2023 Jan; 28(1):402-409. PubMed ID: 36253442
    [Abstract] [Full Text] [Related]

  • 2. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
    Hetrick SE, McKenzie JE, Bailey AP, Sharma V, Moller CI, Badcock PB, Cox GR, Merry SN, Meader N.
    Cochrane Database Syst Rev; 2021 May 24; 5(5):CD013674. PubMed ID: 34029378
    [Abstract] [Full Text] [Related]

  • 3. Vortioxetine for major depressive disorder: An indirect comparison with duloxetine, escitalopram, levomilnacipran, sertraline, venlafaxine, and vilazodone, using number needed to treat, number needed to harm, and likelihood to be helped or harmed.
    Citrome L.
    J Affect Disord; 2016 May 15; 196():225-33. PubMed ID: 26938965
    [Abstract] [Full Text] [Related]

  • 4. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
    Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JPT, Egger M, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Tajika A, Ioannidis JPA, Geddes JR.
    Lancet; 2018 Apr 07; 391(10128):1357-1366. PubMed ID: 29477251
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and tolerability of antidepressant drugs in treatment of depression in children and adolescents: a network meta-analysis.
    Rao Y, Yang R, Zhao J, Cao Q.
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Aug 01; 51(4):480-490. PubMed ID: 37202104
    [Abstract] [Full Text] [Related]

  • 6. Relative efficacy and tolerability of vortioxetine versus selected antidepressants by indirect comparisons of similar clinical studies.
    Llorca PM, Lançon C, Brignone M, Rive B, Salah S, Ereshefsky L, Francois C.
    Curr Med Res Opin; 2014 Dec 01; 30(12):2589-606. PubMed ID: 25249164
    [Abstract] [Full Text] [Related]

  • 7. Beneficial and harmful effects of antidepressants versus placebo, 'active placebo', or no intervention for adults with major depressive disorder: a protocol for a systematic review of published and unpublished data with meta-analyses and trial sequential analyses.
    Juul S, Siddiqui F, Barbateskovic M, Jørgensen CK, Hengartner MP, Kirsch I, Gluud C, Jakobsen JC.
    Syst Rev; 2021 May 25; 10(1):154. PubMed ID: 34034811
    [Abstract] [Full Text] [Related]

  • 8. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
    Cipriani A, Zhou X, Del Giovane C, Hetrick SE, Qin B, Whittington C, Coghill D, Zhang Y, Hazell P, Leucht S, Cuijpers P, Pu J, Cohen D, Ravindran AV, Liu Y, Michael KD, Yang L, Liu L, Xie P.
    Lancet; 2016 Aug 27; 388(10047):881-90. PubMed ID: 27289172
    [Abstract] [Full Text] [Related]

  • 9. Comparative efficacy and acceptability of antidepressants in the long-term treatment of major depression: protocol for a systematic review and networkmeta-analysis.
    Shinohara K, Efthimiou O, Ostinelli EG, Tomlinson A, Geddes JR, Nierenberg AA, Ruhe HG, Furukawa TA, Cipriani A.
    BMJ Open; 2019 May 19; 9(5):e027574. PubMed ID: 31110100
    [Abstract] [Full Text] [Related]

  • 10. Side effect profile and comparative tolerability of 21 antidepressants in the acute treatment of major depression in adults: protocol for a network meta-analysis.
    Tomlinson A, Efthimiou O, Boaden K, New E, Mather S, Salanti G, Imai H, Ogawa Y, Tajika A, Kishimoto S, Kikuchi S, Chevance A, Furukawa TA, Cipriani A.
    Evid Based Ment Health; 2019 May 19; 22(2):61-66. PubMed ID: 30996028
    [Abstract] [Full Text] [Related]

  • 11. Duloxetine versus other anti-depressive agents for depression.
    Cipriani A, Koesters M, Furukawa TA, Nosè M, Purgato M, Omori IM, Trespidi C, Barbui C.
    Cochrane Database Syst Rev; 2012 Oct 17; 10(10):CD006533. PubMed ID: 23076926
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysis.
    Furukawa TA, Salanti G, Atkinson LZ, Leucht S, Ruhe HG, Turner EH, Chaimani A, Ogawa Y, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Suganuma A, Watanabe N, Stockton S, Geddes JR, Cipriani A.
    BMJ Open; 2016 Jul 08; 6(7):e010919. PubMed ID: 27401359
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials.
    Tedeschini E, Levkovitz Y, Iovieno N, Ameral VE, Nelson JC, Papakostas GI.
    J Clin Psychiatry; 2011 Dec 08; 72(12):1660-8. PubMed ID: 22244025
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.